1Y Annualised Return
▲31.91%
3Y Annualised Return
▲35.53%
5Y Annualised Return
▲88.35%
Beta Drugs Stock Performance
|
|
|
Beta Drugs Company background
Founded in: 2005
Managing director: Varun Batra
Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to Beta Drugs Limited on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Companys products range from anticancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new state of the art manufacturing facility for oncology formulations in 2014 developed inhouse Albumin bound Paclitaxel in 2015 started inhouse API Plant Adley Labs in 2017. In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEMRTU, ADLEAP, ADLANTE, BEXINIB launched 1st Indian Brand of Dasatinib, BEEDAN. In 2025, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
Beta Drugs Share Price Today
As of 4 Dec 2025, Beta Drugs share price is ₹1690.6. The stock opened at ₹1761 and had closed at ₹1743.6 the previous day. During today’s trading session, Beta Drugs share price moved between ₹1,680.50 and ₹1,768.90, with an average price for the day of ₹1724.70. Over the last 52 weeks, the stock has recorded a low of ₹1,429.52 and a high of ₹2,190.47. In terms of performance, Beta Drugs share price has declined by 8.8% over the past six months and has increased by 31.91% over the last year.
Beta Drugs SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹51,02,611 in 5 years with a gain of ₹48,02,611 (+1600.87%)
Beta Drugs Fundamental
Market Cap (in crs)
1,706.59
Face Value
10
Turnover (in lacs)
165.02
Key Metrics
Qtr Change %
-9.9
Dividend yield 1yr %
0
Beta Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1690.6
Current Price
Day EMA5
1,697.10
Day EMA10
1,686.00
Day EMA12
1,685.60
Day EMA20
1,694.10
Day EMA26
1,703.60
Day EMA50
1,734.90
Day EMA100
1,762.50
Day EMA200
1,754.70
Day SMA5
1,697.00
Day SMA10
1,669.20
Day SMA20
1,672.40
Day SMA30
1,725.50
Day SMA50
1,748.00
Day SMA100
1,778.40
Day SMA150
1,784.80
Day SMA200
1,774.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 5531 Rs | 9761 Rs |
Week Rs | 5848 Rs | 10002 Rs |
Month Rs | 12967 Rs | 15081 Rs |
Resistance & Support
1,713.33
Pivot
Resistance
First Resistance
1,746.17
Second Resistance
1,801.73
Third Resistance
1,834.57
Support
First Support
1,657.77
Second support
1,624.93
Third Support
1,569.37
Relative Strength Index
47.62
Money Flow Index
67.95
MACD
-18.05
MACD Signal
-29.42
Average True Range
65.49
Average Directional Index
28.31
Rate of Change (21)
-6.94
Rate of Change (125)
-10.74
Beta Drugs Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
668.30 | 1,932.10 | 544.1 | 842.9 | 672.70 | -1.94% | -6.65% | -8.66% | -9.76% | -6.18% | 0.69% | 33.96 | 41.69 | 5.63 | |
154.96 | 1,638.28 | 108.12 | 190.97 | 153.95 | -6.27% | 0.77% | 16.55% | -3.71% | 110.40% | 0.32% | 20.90 | 41.69 | 1.48 | |
42.70 | 2,339.76 | 42 | 91.7 | 43.12 | -2.64% | -11.41% | -33.08% | -50.55% | 38.19% | 0.47% | 41.50 | 41.69 | 1.96 | |
809.10 | 1,997.73 | 744.95 | 1099.9 | 810.10 | -0.31% | -5.70% | -18.37% | -23.46% | 18.74% | 3.09% | 18.74 | 41.69 | 2.58 | |
38.36 | 1,679.71 | 6 | 44.31 | 38.84 | 2.13% | -2.61% | 189.29% | 520.71% | 4,521.69% | 0.03% | 142.07 | 41.69 | 25.53 | |
785.85 | 1,656.35 | 665.1 | 1178.85 | 780.25 | -1.17% | -16.20% | -14.67% | -27.91% | 200.00% | 0.73% | 24.80 | 41.69 | 3.11 |
Beta Drugs Share Price FAQs
How has Beta Drugs shares performed in the past ?
Beta Drugs share price in the past 1-year return was -20.77. The Beta Drugs share hit a 1-year low of Rs. 1429.52 and a 1-year high of Rs. 2190.47.
What is the market cap of Beta Drugs ?
The market cap of Beta Drugs is Rs. 1706.59 Cr. as of 3/12/2025.
What is the current P/E ratio of Beta Drugs ?
The PE ratios of Beta Drugs is 90.99 as of 3/12/2025.
What is the current PB ratio of Beta Drugs ?
The PB ratios of Beta Drugs is 13.22 as of 3/12/2025
How to buy Beta Drugs shares?
You can easily buy Beta Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Beta Drugs ?
The 52-week high and low of Beta Drugs share price is ₹2190.47 and ₹1429.52 as of 3/12/2025.
Please be aware that Beta Drugs stock prices are subject to continuous fluctuations due to various factors.
Invest in Beta Drugs